RxDoctor Payments Data

Tina Gifford, APRN

Family · Maysville, KYNPI 1801417282

Payments from drug & device makers

$490in general payments, 2019–2025

Across 27 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$206
  • AstraZeneca$84
  • Exact Sciences$38
  • Otsuka America Pharmaceutical, Inc.$37
  • Dexcom, Inc.$24
  • Organon$23
  • plus $78 from 5 others

What the payments were for

  • Food & beverage$490100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$490 in reported general payments places this provider in the 50th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$51,084
Medicare patients
177
Services billed
661

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide40$46,777
XareltoRivaroxaban38$32,536
JardianceEmpagliflozin33$29,534
EliquisApixaban28$28,438
OzempicSemaglutide25$28,090
JanuviaSitagliptin Phosphate15$24,686
JanumetSitagliptin Phos/Metformin Hcl15$9,442
SymbicortBudesonide/Formoterol Fumarate11$3,298
Levothyroxine Sodium305$2,947
SynthroidLevothyroxine Sodium27$2,484
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,295
Albuterol Sulfate HfaAlbuterol Sulfate57$1,571
Omeprazole184$1,515
Trazodone Hcl50$1,254
Gabapentin147$1,211

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$15$46,77740 claims
Boehringer IngelheimJardiance$15$29,53433 claims
PfizerEliquis$17$28,43828 claims
Novo NordiskOzempic$16$28,09025 claims
AstraZenecaSymbicort$84$3,29811 claims
AbbVieSynthroid$206$2,48427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,374 family providers in Kentucky.

Other family in Maysville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →